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ABSTRACT
Mischarging of the vallne specific tRNA-like structure
of turnip yellow mosaic virus (TYMV) RNA has been
tested In the presence of purified arginyl-, aspartyl-,
histidlnyl-, and phenylalanyl-tRNA synthetases from
bakers' yeast. Important mischarging of a 264
nucleotide-long transcript was found with histidinyl-
tRNA synthetase which can acylate this fragment up
to a level of 25% with a loss of specificity (expressed
as Vmax/Ku ratios) of only 100 fold as compared to a
yeast tRNA"* transcript. Experiments on transcripts of
various lengths indicate that the minimal valylatable
fragment (n = 88) is the most efficient substrate for
histidinyi-tRNA synthetase, with kinetic characteristics
similar to those found for the control tRNAHl8
transcript. Mutations in the antteodon or adjacent to the
3' CCA that severely affect the valylation capacity of
the 264 nucleotlde long TYMV fragment are without
negative effect on its mischarging, and for some cases
even improve its efficiency. A short fragment (n = 42)
of the viral RNA containing the pseudoknot and
corresponding to the amino acid accepting branch of
the molecule is an efficient hlstidine acceptor.
INTRODUCTION
The genomic RNAs of a number of positive strand RNA plant
viruses possess at their 3' ends a tRNA-like structure that is able
to interact with various tRNA specific proteins, including
aminoacyl-tRNA synthetases, (ATP, CTP):tRNA nucleotidyl
transferase, elongation factors and RNAse P (reviewed in 1). The
most characteristic feature of these molecules is their ability to
be efficiently aminoacylated in vitro (e.g. 2 -5 ) and indeed
aminoacylation also occurs in vivo (6—8), in competition with
the charging of cellular tRNAs. The role of aminoacylation in
the viral life cycle remains unknown. Based on work with brome
mosaic virus (BMV) showing that the tRNA-like structure is
involved both in tRNA mimicry and in genome replication
(9—12), hypotheses have favoured a role for aminoacylation in
RNA replication (13). A role in the coordination of genome
expression and replication is also possible (14). There is no
evidence that aminoacylated tRNA-like structures are able to
interact with ribosomes to, for instance, modify protein synthesis
profiles during viral infection (15), an idea supported by recent
studies on BMV RNA (16). Further, it is uncertain at present
whether aminoacylation is an essential function for all the
aminoacylatable viral RNAs. Aminoacylation in vitro and virus
replication in vivo are highly correlated for turnip yellow mosaic
virus (TYMV) RNA (17), but apparently not for BMV RNA (12,
18). The fact that the viral tRNA-like structures are substrates
for (ATP, CTP):tRNA nucleotidyl transferase suggests a role
for these structures as telomeres (19, 20), a property that has
been demonstrated in the case of BMV (21).
Only a limited number of aminoacyl-tRNA synthetases have
been found to acylate plant viral RNAs, which have been
considered to be specific substrates for the relevant aminoacyl-
tRNA synthetases : tymoviral RNA for valyl-tRNA synthetase
(ValRS), bromo-, cucumo- and hordeiviral RNA for tyrosyl-
tRNA synthetase (TyrRS), and tobamoviral RNA (with one
exception) for histidinyl-tRNA synthetase (HisRS) (1).
Recognition by a limited set of aminoacyl-tRNA synthetases could
be due to peculiar structural features of those synthetases that
are able to accommodate the non-canonical viral tRNAs. In this
paper we investigate further whether viral RNAs can be
significantly charged by aminoacyl-tRNA synthetases other than
their 'cognate' enzymes listed above, including synthetases not
currently known to charge viral RNAs. This possibility is
suggested by the fact that certain canonical tRNAs, in particular
valine-specific tRNAs, are well known to be mischarged by
different aminoacyl-tRNA synthetases (e.g. 22-25). Mischarging
of viral RNAs might also be expected due to the lack of modified
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bases, whose absence in tRNA transcripts causes a structural
relaxation (26), that results in relaxed specificity : e.g. unmodified
yeast tRNA^ transcripts have enhanced mischarging by ArgRS
(27). As our model molecule for these studies we have chosen
the valylatable TYMV RNA, whose tRNA-like structure most
closely resembles canonical tRNAs (Fig. 1A), and which might
therefore be most readily recognized by other synthetases. The
selection of TYMV RNA was further supported by the
observation of Van Belkum et al. showing that a crude
Escherichia coli synthetase preparation could incorporate
radioactive amino acids other than valine in RNA extracted from
TYMV virions (28). However, the possibility that contaminating
tRNA was present was not excluded in this work.
In the present studies, we have tested the charging of various
TYMV RNA 3' end fragments prepared by in vitro transcription
using four highly enriched yeast aminoacyl-tRNA synthetases,
and have found significant aminoacylation by HisRS. Kinetic data
characterizing this novel mischarging reaction of TYMV RNA
will be presented and virological implications as well as the
perspectives for the tRNA/synthetase recognition problem will
be discussed.
MATERIALS AND METHODS
Materials
Yeast ValRS, AspRS and ArgRS were purified to homogeneity
according to established procedures (29—31). Yeast HisRS was
an enzyme preparation enriched by chromatographies on DEAE-
cellulose, hydroxyapatite and phosphocellulose (32). Pure yeast
PheRS was a gift from M. Baltzinger (IBMC, Strasbourg). Yeast
tRNAVal was purified according to an established procedure
(29). T7 RNA polymerase was prepared according to (33).
L-[3H] valine (25 Ci/mmol), L-[3H] phenylalanine (30
Ci/mmol), L-[3H] aspartic acid (20 Ci/mmol), L-[14C] arginine
(58 Ci/mmol), and L-[I4C] histidine (300 mCi/mmol) were from
Amersham France (Les Ulis). Restriction enzymes BstNl and
EcoT22I were purchased from New England Biolabs (Beverly,
MA, USA) and United States Biochemical Corporation
(Cleveland, OH, USA), and RNAsin from Promega (Madison,
WI, USA).
Cloning of synthetic genes containing the TYMV tRNA-like
structure
cDNAs corresponding to different lengths of the TYMV RNA
3' end were cloned next to the T7 RNA polymerase promoter
into plasmid pIBI76 as described by (11). These clones containing
cDNA of 258, 109, and 82 nucleotides from the viral sequence
and an additional GGGAGA hexanucleotide sequence at their
5'-end, were named pTYSma, pTYDde and pTYAlu,
respectively. They contain a BstNl restriction site at the precise
end of the sequence encoding the tRNA-like sequence. Mutations
have been introduced into clone pTYSma, giving rise to
transcripts differing from the wild-type sequence in the middle
position of the CAC anticodon (pTYSma-G56, pTYSma-U56)
or adjacent to the 3' CCA terminus (pTYSma-C4 and pTYSma-
G4). Clone pTYAA consisting of the amino acid accepting arm
(n=42) of the TYMV tRNA-like structure adjacent to the T7
RNA polymerase promoter was created by oligonucleotide-
directed mutagenesis of pTYAlu. Site directed mutagenesis has
been performed as described in (34).
Cloning of synthetic yeast tRNA"* gene
Ten oligonucleotides corresponding to the consensus sequence
of the T7 RNA polymerase promoter and to the sequence of yeast
tRNA11" were ligated and inserted into a derivative of pUC18
linearised with BamHI and HindHI as described for yeast
tRNA1^5 synthetic gene (26). This plasmid contains also the
origin of replication of phage Fl and an ampicilline resistance
gene. An EcoT22I restriction site was introduced at the end of
the tRNA sequence. This allows, after linearisation of the plasmid
and transcription, for the production of transcripts ending with
a 3' CCA sequence. BstNl, the restriction enzyme generally used
for linearisation of DNA encoding tRNA sequences, could not
be used here since there is an internal BstNl site in the tRNA
sequence.
In vitro transcription
Since the efficiency of in vitro transcription by T7 RNA
polymerase is extremely sensitive to the sequence downstream
the promoter, experimental conditions have been worked out for
the three types of molecules studied. Plamsids encoding the
TYMV sequences (except pTYAA) were linearized with BstNl
and transcribed as described in (34) except that the temperature
was 30°C. pTYAA, encoding the 42 nucleotide long acceptor
arm was transcribed under the following conditions:
BstNl-linearised plasmid (15 /tg) was incubated 4 hours at 37°C
in 40 mM Tris-HCl pH 8.1 (at 37°C), 20 mM MgCl2, 1 mM
spermidine, 10 mM dithioerythritol, 0.01% Triton X 100, 4 mM
of each nucleoside triphosphate, 120 U RNAsin and 150 U of
T7 RNA polymerase in 150 y.\. After phenol extraction and
ethanol precipitation, the tRNA-like transcripts were purified by
HPLC on a TSK^OO column (Biorad, Paris, France) in 0.2 M
sodium acetate pH 6.5, 1 % methanol. Fractions containing full-
length transcripts were ethanol precipitated. Since T7 RNA
polymerase adds generally one or two additional nucleotides to
the 3' end of transcripts, estimation of the concentrations of the
correct ending 3' CCA species in each batch of transcripts was
performed according to (11).
For the tRNAHis transcripts, double stranded plasmid
encoding the tRNA sequence was linearised by EcoT22I and
transcribed in vitro as described in (26). After phenol extraction,
transcripts were ethanol precipitated and purified by 12% PA-
GE followed by electroelution. This allowed to separate
transcripts ending with the correct 3' sequence from those
presenting one or two additional nucleotides.
Aminoacylation assays
Aminoacylation assays were performed at 30°C in either 55 mM
Tris-HCl pH 7.5, 15 mM MgCl2, 10 mM ATP, 2.5 mM
glutathione, 30 mM KC1, 50 /tM labelled amino acid (condition
1) or 25 mM Tris-HCl pH 8.5, 7.5 mM MgCl2, 0.5 mM ATP,
50 ftM labelled amino acid (condition 2), and the required
concentrations of transcript and aminoacyl-tRNA synthetase.
Aliquots were spotted on 3MM Whatman paper at different times
and trichloroacetic acid precipitated. Kinetic parameters (KM
and V^m) were determined from Lineweaver-Burk plots.
Periodate oxidation
Oxidation of the 3' terminal adenosine of the TYSma transcript
was performed on 40 /tM RNA by 1 mM sodium periodate in
darkness during 45 min. Reaction was stopped by glycerol
(10 mM final concentration). After 5 min incubation, the
transcript was ethanol precipitated and dried.
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RESULTS AND DISCUSSION
Search of aminoacyl-tRNA synthetases that catalyse the
mischarging of TYMV RNA
In previous work we have shown that an in vitro transcript
corresponding to the 258 nucleotides from the 3' end of TYMV
(plus 6 extra non-viral nucleotides at the 5' end) (Fig. 1A) is
a very efficient substrate for ValRS (11). The ability of this
transcript (TYSma) to be charged by four aminoacyl-tRNA
synthetases other than ValRS has now been tested. Of the four
aminoacyl-tRNA synthetases tested, those specific for arginine,
aspartic acid, histidine and phenylalanine, only HisRS gave
charging levels above background (Table 1). The maximal
histidinylation plateaus reached were 0.25 mol/mol of input
valylatable transcripts ; the plateaus were sensitive to the enzyme
concentration (not shown) as well as to solvent conditions. While
histidine charging reached about 0.13 mol/mol at a Mg2+/ATP
ratio of 1.5, it is increased to 0.25 mol/mol at a Mg2+/ATP
ratio of 15 (Table 1). This behaviour is reminiscent of that
observed in many mischarging reactions of canonical tRNAs
(e.g.(35)). The inability of periodate-oxidized transcript to accept
histidine (not shown) demonstrates that the histidinylation of
TYSma is not artefactual. No mischarging by ArgRS, AspRS,
or PheRS were observed in a variety of experimental conditions,
including in the presence of dimethylsulfoxide, an additive known
to stimulate incorrect aminoacylations (35, 36).
These results indicate that identity elements recognized by yeast
HisRS are present in the TYMV tRNA-like structure (discussed
below). Interestingly, Van Belkum et al. (28) also observed
histidine charging with RNAs extracted from TYMV virions
(0.08 mol/mol). On the basis of the results in Table 1, we suggest
that the data of the dutch group were not due to contaminating
tRNAHts but rather reflect histidinylation of the viral RNA by
E. coli HisRS. The absence of charging by PheRS, AspRS and
ArgRS presumably reflects either the absence within the TYMV
transcript of sufficient identity elements specific for these
synthetases, or the presence of conformational features (e.g. the
pseudoknot) that prevent a productive interaction between the
viral RNA and these synthetases, or both. It seems likely that
conformational incompatibility is the major reason for the lack
of phenylalanylation: the TYMV tRNA-like structure possesses
two identity nucleotides of yeast tRNA"* (in the anticodon, and
at the discriminator base adjacent to the 3' CCA) (37), as does
E. coli tRNAVal (38) which is mischarged by yeast PheRS.
It is interesting that the newly discovered histidinylation of
TYMV RNA involves an aminoacyl-tRNA synthetase that is
already known to charge viral RNAs, those of the tobamoviruses,
including tobacco mosaic vims (39). ValRS and HisRS belong
to aminoacyl-tRNA synthetase class I and II, respectively (40),
suggesting that the recognition and charging of extra-large non-
canonical substrates is not a characteristic of a single class, and
is thus not related to the structural motifs or reaction mechanisms
of a specific class. Additional mischargings of viral tRNA-like
structures, including TYMV RNA, cannot thus be excluded, but
await further studies. ThrRS could be a potential candidate
catalyzing such mischarging since it was already shown that it
can accomodate an extra-large RNA substrate (41,42). This holds
true for ArgRS (43) and AspRS (43) which could possibly charge
tRNA-like structures other than TYMV.
Comparison between the histidinylation of TYSma RNA
(n=264 nt) and a yeast tRNA1"* transcript
A Lineweaver-Burk analysis of the histidinylation of TYSma
RNA and a yeast tRNAHis transcript (Fig. IB) by yeast HisRS
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Fig. 1. (A) Partial sequence of three transcripts of the TYMV RNA 3' end emphasizing the L-shaped region of the tRNA-like molecules. Nucleotides thai are major
valine identity determinants and at which substitutions (indicated) in the TYSma transcripts have been studied are shaded. All three transcripts have non-viral 5'-GGGAGA
sequences, followed by TYMV sequences of the indicated length upstream of the 82 nucleotides comprising the tRNA-like structure. Nucleotides are numbered
from the 3' end. (B) Sequence of yeast tRNAHl* transcript (51). (C) Minihelix mimicking the amino acid acceptor arm of TYMV RNA. In order to provide a G
residue for initiation of transcription by T7 RNA polymerase, the pseudoknot has been modified from that of TYMV RNA: the acceptor minihelix is built up of
three successive helices of 3, 4 and 5 base-pairs instead of 4, 3 and 5 ; this was achieved by insertion of a C residue between U12 and G13 and the concomitant
deletion of C42. As a consequence, loop L2 crosses 4 base-pairs instead of 3.
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was made, using experimental conditions favouring the
mischarging of the viral RNA (i.e. Mg^/ATP ratio of 15). The
tRNAHis transcript was clearly a better substrate than the
TYSma transcript (Table 2). The suboptimal nature of TYSma
RNA as a HisRS substrate appears not to be due to poor
recognition, since KM was even reduced by a factor of about 3
relative to the tRNA"0 transcript. There is significant kinetic
discrimination, however, evidenced by a V,,^ that is reduced
by a factor of 275 as compared to the tRNAHis transcript. The
loss of specificity as a substrate for yeast HisRS, expressed as
the relative V ^ / K M , was thus 100-fold. This loss in specificity
is relatively moderate when compared to values determined for
the mischarging of canonical tRNAs: for instance, a 12000-fold
loss for yeast tRNAMa mischarging by yeast ValRS (relative to
yeast tRNAVl)) (5) and a 13000-fold loss for yeast t R N A ^
mischarging by yeast ArgRS (relative to yeast tRNA^) (27).
Histidinylation of TYMV fragments of various lengths
Because fragments considerably shorter than the 264 nucleotide-
long TYSma RNA are capable of mimicking the L-shaped fold
of a tRNA (82 nt; Fig. 1 A) (44, 45) and of supporting valylation
(82 —84 nt) (11, 46), we tested the histidinylation properties of
two shorter RNAs containing the tRNA-like structure, TYDde
(109 viral nt) and TYAlu (82 viral nt). Both RNAs were more
efficiently histidinylated than TYSma (Table 2). Transcript
TYAlu, which is the shortest RNA capable of forming a complete
tRNA-like structure, appears to be a very good substrate for yeast
HisRS, with only a 5-fold loss of specificity ( V ^ / K M relative
Table 1. Level of charging (% of aminoacylation) of TYSma transcript by various
yeast aminoacyl-tRNA synthctases.
yeast aminoacyl-tRNA synthetase
(specificity)
Valine
Arginine
Aspartic acid
Histkline
Phenylalanine
condition 1 •
100%
< 1 %
< 1 %
13%
< 1 %
condition 2 *
100%
< 1 %
< 1 %
25%
< 1 %
• See section Materials and Methods for details. Aminoacylation extents were
calculated taking into account a percentage of 50% of the transcripts terminating
with the CCA sequence.
to that of the tRNAHij transcript). Thus, it appears that the
minimal sequence involved in folding the tRNA-like structure
contains all the important features to make TYMV RNA a good
substrate for yeast HisRS, and that the 5' flanking region has
a negative influence on the histidinylation reaction, perhaps by
acting as a structural antideterminant (27) that hinders recognition
by the HisRS.
Histidinylation of a minihelix containing a pseudoknot
While aminoacyl-tRNA synthetases in some cases accept extra-
large non-canonical substrates such as the viral tRNA-like
structures, certain synthetases are able to aminoacylate
minisubstrates. This was first demonstrated for E. coli AlaRS,
which can efficiently charge alanine onto a minihelix that mimics
the amino acid acceptor arm of tRNA*18 (47), and has
subsequently been observed in the histidine system from E. coli
(48). Accordingly, we cloned and transcribed in vitro an RNA
fragment that mimics the amino acid acceptor arm of the TYMV
tRNA-like structure and tested its histidinylation properties. This
transcript, TYAA (Fig. 1C), was designed to contain a
pseudoknot slightly different from that of TYMV RNA (see
Fig. 1A, 1C) in order to accommodate 5' sequences necessary
for efficient transcription by T7 RNA polymerase. TYAA RNA
is indeed a substrate for yeast HisRS (Table 2). This non-
canonical minihelix is well recognized by the synthetase as
deduced from the KM which is approximately the same as that
of the tRNA110 transcript, and, although the V ^ is decreased
by a factor of 68 relative to that of the tRNAHis transcript, the
histidinylation specificity (relative V ^ / K M ) is decreased by
only a factor of 55.
The aminoacylation of a short pseudoknotted fragment of viral
RNA suggests that as yet undetected truncated tRNA-like
structures with tRNA mimicry may be present in RNA viral
genomes. Interestingly, the 3' end of tobacco rattle viral RNA
can be folded into a pseudoknotted structure like an amino acid
acceptor arm, although no anticodon-like region or entire re-
shaped tRNA-like structure exists (49). This holds true for phage
MS2 RNA with the difference that there is no pseudoknotted
structure in the acceptor arm (50). Although no aminoacylation
of these viral RNAs has been detected, it is possible that they
evolved from progenitors with entire tRNA-like structures capable
of aminoacylation or alternatively, they may represent a step in
evolution towards molecules more closely mimicking tRNA.
Table 2. Kinetic parameters of histidinylation of various TYMV RNA transcripts, of natural tRNAv>1, and of yeast tRNAHu transcript.
RNA
tRNAHB transcript
TYSma (n=264»)
TYDde (n=115*)
TYAlu (n=88»)
TYAA (n-42)
TYSma-G56*
TYSma-U56*
TYSma-C4»
TYSma-G4*
yeast tRNAVl)
Level of
histidinylation
100%
25%
60%
85%
35%
85%
95%
45%
60%
30%
KM
(nM)
415
155
725
290
345
50
45
240
200
320
(arbitrary units)
8500
31
280
1240
125
45
45
no
40
25
VH^/KM
(arbitrary units)
20
0.20
0.38
4.27
0.36
0.9
1.0
0.45
0.20
0.08
Loss of
specificity
1
100
53
4.7
55
22
20
44
100
250
* These transcripts of 258, 109 and 82 genomic nucleotides, respectively, contain a 5' extension of 6 nucleotides originating from the cloning process.
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Relationship between histidine and valine identities
These studies report the first direct evidence for an efficient
mischarging of a tRNA-like molecule, and demonstrates that the
3' end of TYMV RNA (at least for short fragments) has a dual
specificity for both ValRS and HisRS. Since the major identity
elements for specific valylation of TYMV RNA by yeast ValRS
have been found (34), it was possible to verify whether these
are also involved in histidine charging. To determine whether
the identity elements for valylation and histidinylation are
overlapping or independent, we tested the histidine charging of
variants of the TYSma transcript mutated in the nucleotides with
major valine identity, namely trie middle position of the anticodon
and the residue adjacent to the 3' CCA end. All mutants (TYSma-
G56, TYSma-U56, TYSma-C4 and TYSma-G4) were efficiently
recognized and charged by HisRS, as seen by comparison of the
kinetic parameters of histidinylation summarized in Table 2. By
contrast, these mutants had lost significant valylation specificity,
with V ^ / K M values decreased by 29 to 28000-fold relative to
TYSma (34). Thus, it is clear that the set of identity nucleotides
recognized by ValRS and HisRS are different and independent.
The identity determinants for yeast HisRS have not previously
been described. Our results clearly show that major histidine
determinants are located within the amino acid acceptor stem of
TYMV RNA. Comparison of the sequences of all eucaryotic
tRNAHis species (51) reveals as an unique feature the presence
of a G residue at position - 1 at the 5' end of these tRNAs. The
analogous nucleotide in TYAA RNA is U22 within loop LI of
the pseudoknot (note that numbering of the viral tRNA-like
structure begins at the 3' adenosine). On the basis of experimental
and theoretical studies (45, 52), this uracil 22 was proposed to
be stacked on top of the major helix of the acceptor arm, in a
position to base-pair with nucleotide A4. Since the mutants
TYSma-C4 and TYSma-G4 have kinetic parameters similar to
that of TYSma (Table 2), it is clear that the presence of a base-
pair involving A4 at the end of the amino acid acceptor arm is
not important for histidinylation. Indeed, yeast tRNAHis does not
have a —1/73 base-pair (51), and presumably G-l is able to stack
on top of Gl in the acceptor helix, as is proposed for the U residue
of pseudoknot loop LI of TYMV RNA. We suggest that the
phosphate backbone of this stacked extension of the amino acid
acceptor stem is a critical feature recognized by HisRS, since
little or no sequence specificity has been observed (Table 2). This
feature seems to be retained in evolution since nucleotide G-l
is the major identity element in E. coli tRNAHis (53) and may
explain the weak histidinylation of yeast tRNAVaI (Table 2).
Possibly, the sequence or topology of the acceptor arm (compare
in Fig. 1 the pseudoknot design in the minihelix and the wild-
type TYMV RNA sequence) may also play a role in the histidine
identity of TYMV RNA, but alternatively the more efficient
histidinylation of TYAJu relative to TYAA could also suggests
the presence of additional histidine identity elements within the
tRNA-like structure outside the amino acid acceptor arm.
Perspectives and virological implications
A comparison of the valylation and histidinylation efficiencies
of TYMV RNA indicates that the viral RNA should be considered
an RNA specific for valine charging, but which can be
significantly mischarged with histidine. The valylation of TYMV
RNA is about 20 times less efficient than that of yeast tRNAVal
(5) while we have shown here that the histidinylation of TYSma
RNA is about 100 times less efficient than that of the yeast
tRNAHis transcript. Nevertheless, it will be of great interest to
determine whether TYMV RNA can be significantly
histidinylated by a more homologous HisRS of higher plant origin
in vitro and in vivo during infection. If in vivo histidinylation
of TYMV RNA is in fact significant, then TYMV RNAs with
anticodon mutations that destroy valylation should similarly be
histidinylated (see TYSma-G56 or TYSma-U56, Table 2). Since
such mutants replicated at only very low rates in Chinese cabbage
protoplasts (17), the observed correlation between valylation and
replication (17) could be considered to refer specifically to
valylation rather than to aminoacylation in general. Alternatively,
if higher plant HisRS is unable to charge TYMV RNA as well
as the yeast enzyme, then the results reported here provide
encouragement that a TYMV RNA with improved histidine
identity can be constructed by mutagenesis to test the effect of
histidinylation during infection.
Our findings on the dual charging of TYMV RNA fragments
are relevant to the cowpea strain of tobacco mosaic virus
(CcTMV), which in contrast to other tobamoviruses binds valine
rather than histidine (54) and has a tRNA-like structure similar
to that of TYMV. Using a mixture of yeast aminoacyl-tRNA
synthetases, a very low but significant histidine charging (0.01
mol/mol) of CcTMV RNA was found (54). Our findings on the
histidinylation of TYMV RNA open the possibility that CcTMV
RNA likewise possesses significant histidine identity, perhaps
more so as a substrate for higher plant than for yeast HisRS
(histidinylation by yeast HisRS seems to be minimal (54)), and
that such histidinylation may be relevant to the replication of this
tobamoviral RNA.
ACKNOWLEDGEMENTS
We thank Dr. F.W.Studier (Brookhaven) for T7 RNA
polymerase clone. This work was supported by grants from the
Centre National de la Recherche Scientifique (CNRS), Ministere
de la Recherche et de la Technologie (MRT), University Louis
Pasteur (Strasbourg), National Science Foundation (to TWD),
and by an award from the Human Frontier Science Program.
REFERENCES
1. Mans, R.M.W., Pleij, C.W.A. and Bosch, L. (1991) Eur. J. Biochem, 201,
303-324.
2. Pinck, M., Yot, P., Chapeville, F. and Duranton, H. (1970) Nature 226,
954-956.
3. Hall, T.C., Shih, D.S. and Kaesberg, P. (1972) Biochem. J. Y29, 969-976.
4. Kohl, R.J. and Hall, T.C. (1974)/ Gen. Virol. 25, 257-261.
5. Giege\ R., Briand, J.P., Mengual, R., Ebel, J.P. and Hirth, L. (1978) Eur.
J. Biochem. 84, 251-256.
6. Joshi, S., Hacnni, A.L., Hubert, E., Huez, G. and Marbaix, G. (1978) Naturr
275, 339-341.
7. Loesch-Fries, L.S. and Hall, T.C. (1982) Nature 298, 771-773.
8. Joshi, S., Chapeville, F. and Hacnni, A.L. (1982) EMBOJ. 1, 935-938.
9. Dreher, T.W., Bujarski, J.J. and Hall, T.C. (1984) Nature 311, 171 -175.
10. Miller, W.A., Bujarski, J.J., Dreher, T.W. and Hall, T.C. (1986)/. Mot.
Biot. 187, 537-546.
11. Dreher, T.W., Florentz, C. andGiege, R. (1988) ftocfcwo>70, 1719-1727.
12. Dreher, T.W., Rao, A.L.N. and Hall, T.C. (1989) / . Mot. Bid. 206,
425-438.
13. Dreher, T.W. and Hall, T.C. (1988) In 'RNA Genetics' (Domingo, E.,
Holland, J.J. and Ahlquist, P. eds) vol. 1, pp. 91 -113, CRC Press Inc.,
Boca Raton, Florida.
14. Florentz, C , Briand, J.P. and Giege, R. (1984) FEBSLett. 176, 295-300.
15. Haenni, A.L., Joshi, S. and Chapeville, F. (1982) Prog. Nucl. Add Res.
Mot. Biol. 27, 85-104.
16. Quivy, J.P. and Chroboczek, J. (1991) Biochimie 73, 1269-1273.
17. Tsai, C.H. and Dreher, T.W. (1991) / . Virol. 65, 3060-3067.
18. Dreher, T.W. and Hall. T.C. (1988)/. Mot. Biol. 201, 41-55 .
Downloaded from https://academic.oup.com/nar/article-abstract/20/8/1865/2376582
by UNIVERSITE LOUIS PASTEUR - SCD user
on 11 April 2018
1870 Nucleic Acids Research, Vol. 20, No. 8
19. Weiner, A.M. and Maizels, N. (1987) Proc. Natl. Acad. Sci. U.S.A. 84,
7383-7387.
20. Gallic, D.R., Feder, J.N., Schimke, R.T. and Walbot, V. (1991) Nucleic
Acids Res. 19, 5031-5036.
21. Rao, A.L.N., Dreher, T.W., Marsh, L.E. and Hall, T.C. (1989) Proc. Nail.
Acad. Sci. U.S.A. 86, 5335-5339.
22. Mertes, M., Peters, M.A., Mahoney, W. and Yarus, M. (1972) J. Mol.
Biol. 71, 671-685.
23. Ebel, J.P., Giege\ R., Bonnet, J., Kern, D., Befort, N., Bollack, C , Fasiolo,
F., Gangloff, J. and Dirheimcr, G. (1973) Biochimie 55, 547-557.
24. Gtege\ R., Kem, D., Ebel, J.P., Grosjean, H., De Henau, S. and Chantrenne,
H. (1974) Eur. J. Biochem. 45, 351-362.
25. Grosjean, H., Charlier, J., Dane, C , Dirheimer, G., Giegc', R., De Henau,
S., Keith, G., Parfait, R. and Takada, C. (1976) Exptrientia VH-Zitl.
26. Perret, V., Garcia, A., Puglisi, J., Grosjean, H., Ebel, J.P., Florcntz, C.
and Giege, R. (1990) Biochimie 72, 735-744.
27. Perret, V., Garcia, A., Grosjean, H., Ebel, J.P., Florentz, C. and Giegf,
R. (1990) Nature 344, 787-789.
28. Van Belkum, A., Bingkun, J., Rietveld, K., Pleij, C.W.A. and Bosch, L.
(1987) Biochemistry 26, 1144-1151.
29. Kem, D., Giege\ R., Robbe-Saul, S., Boulanger, Y. and Ebel, J.P. (1975)
Biochimie SI, 1167-1176.
30. Lorber, B., Kem, D., Dietrich, A., Gangloff, J., Ebel, J.P. and Giege\ R.
(1983) Biochem. Biophys. Res. Commun. 117, 259-267.
31. Gangloff, J., Schutz, A. and Dirheimer, G. (1976) Eur. J. Biochem. 65,
177-182.
32. Mengual, R. (1977) These de 1'Universitf Louis Pasteur, Strasbourg, France.
33. Wyatt, J.R., Chastain, M. and Puglisi, J.D. (1991) BioTechniques 11,
764-769.
34. Florentz, C , Dreher, T.W., Rudinger, J. and Giege, R. (1991) Eur. J.
Biochem. 195, 229-234.
35. Giege\ R., Kern, D. and Ebel, J.P. (1972) Biochimie 54, 1245-1255.
36. Yarus, M. and Mertes, M. (1973) J. Biol. Oxem. 248, 6744-6749.
37. Sampson, J.R., DiRenzo, A.B., Behlen, L.S. and UWenbeck, O.C. (1989)
Science 243, 1363-1366.
38. Kem, D., Giege, R. and Ebel, J.P. (1972) Eur. J. Biochem. 31, 148-155.
39. Oberg, B. and Philipson, L. (1972) Biochem. Biophys. Res. Commun. 48,
927-932.
40. Eriani, G., Delarue, M., Poch, O., Gangloff, J. and Moras, D. (1990) Nature
347, 203-206.
41. Moine, H., Romby, P., Springer, M., Grunberg-Manago, M., Ebel, J.P.,
Ehresmann, C. and Ehresmann, B. (1988) Proc. Natl. Acad. Sci. U.S.A.
85, 7892-7896.
42. Graffe, M., Doodon, J., Caillet, J., Romby, P., Ehresmann, C , Ehresmann,
B. and Springer, M. (1992) Science in press.
43. Perret, V., Florentz, C. and Giege, R. (1990) FEBS Lett. 270, 4 - 8 .
44. Rietveld, K., Van Podgeest, R., Pleij, C.W.A., Van Boom, J.H. and Bosch,
L. (1982) Nucleic Acids Res. 10, 1929-1946.
45. Dumas, P., Moras, D., Florentz, C , Giegd, R., Vcrlaan, P., Van Belkum,
A. and Pleij, C.W.A. (1987) J. Biomol. Struc. Dyn. 4, 707-728.
46. Joshi, S., Chapeville, F. and Haenni, A.L. (1982) Nucleic Acids Res. 10,
1947-1962.
47. Franclclyn, C. and Schimmel, P. (1989) Nature 337, 478-481.
48. Francklyn, C. and Schimmel, P. (1990) Proc. Natl. Acad. Sci. U.S.A. 87,
8655-8659.
49. Van Belkum, A., Comelissen, B., Linthorst, H., Bol, J., Pleij, C. and Bosch,
L. (1987) Nucleic Acids Res. 15, 2837-2850.
50. Adhin, M.R., Alblas, J. and Van Duin, J. (1990) Biochim. Biophys. Acta
654, 249-255.
51. Sprinzl, M., Dank, N., Nock, S. and Scnon, A. (1991) Nucleic Adds Res.
19, Supplement, 2127-2171.
52. Puglisi, J.D., Wyatt, J.R. and Tinoco, I. (1991) Ace. Chem. Res. 24,
152-158.
53. Himeno, H., Hasegawa, T., Ueda, T., Watanabe, K., Mhira, K. and Shimizu,
M. (1989) Nucleic Acids Res. 17. 7855-7863.
54. Beachy, R.N., Zaitlin, M., Bruening, G. and Israel, H.W. (1976) Virology
73, 498-507.
Downloaded from https://academic.oup.com/nar/article-abstract/20/8/1865/2376582
by UNIVERSITE LOUIS PASTEUR - SCD user
on 11 April 2018
